Now, scientists say this microscopic gold particles may be able to change that. Thanks to their unique light-absorbing and chemical properties, gold nanoparticles can be engineered to detect telltale biological signs of Parkinson’s—such as abnormal clumps of a protein called α-synuclein—in blood or spinal fluid samples.
“This could be a game-changer,” one researcher noted. “Gold nanoparticles allow us to pick up very faint signals that current methods miss. If we can diagnose Parkinson’s before symptoms set in, we have a much better chance of slowing its progression.” Beyond lab tests, experts believe this technology could pave the way for portable, low-cost diagnostic kits, making early Parkinson’s detection more accessible worldwide.
However, challenges remain. Scientists must ensure the tests are highly accurate and safe for use in humans. Large-scale clinical trials will be needed before gold nanoparticle-based diagnostics reach hospitals and clinics.
